NVWM LLC’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$535 Hold
3
– – ﹤0.01% 708
2026
Q2
$450 Buy
+3
New +$326 ﹤0.01% 694
2021
Q4
– Sell
-7,337
Closed -$917K – 511
2021
Q3
$917K Sell
7,337
-50
-0.7% -$5.94K 0.33% 119
2021
Q2
$918K Buy
7,387
+26
+0.4% +$3.5K 0.33% 115
2021
Q1
$1.12M Sell
7,361
-145
-2% -$21.9K 0.45% 68
2020
Q4
$968K Buy
7,506
+221
+3% +$25.4K 0.4% 85
2020
Q3
$814K Buy
7,285
+11
+0.2% +$1.01K 0.38% 89
2020
Q2
$590K Buy
7,274
+377
+5% +$30.4K 0.32% 98
2020
Q1
$480K Buy
6,897
+592
+9% +$45.4K 0.33% 91
2019
Q4
$493K Buy
+6,305
New +$454K 0.3% 107

Other funds holding GH

NVWM LLC's GH Position: Q3 2026 in Review

NVWM LLC held its Guardant Health (GH) position steady in Q3 2026 at 3 shares worth $535. The position accounts for ﹤0.01% of the portfolio, ranked #708.

NVWM LLC first reported a position in GH in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.12M in Q1 2021. 176 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • NVWM LLC held 3 shares of Guardant Health worth $535 as of Q3 2026.
  • NVWM LLC left its Guardant Health share count unchanged in Q3 2026.
  • Guardant Health made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #708 holding.
  • NVWM LLC first reported a position in Guardant Health in Q4 2019 and has held it in 10 quarters since.
  • NVWM LLC's Guardant Health position peaked at $1.12M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.